Header Logo

Mehrian Jafarizade

Concepts (69)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Interleukin-27
1
2021
7
0.680
Why?
Atherosclerosis
3
2021
165
0.650
Why?
Venous Thromboembolism
3
2019
154
0.380
Why?
Benzamides
2
2019
69
0.280
Why?
Pyridines
2
2019
122
0.270
Why?
Fibrinolytic Agents
2
2019
184
0.250
Why?
Percutaneous Coronary Intervention
2
2020
227
0.230
Why?
Coronary Artery Disease
2
2020
328
0.230
Why?
Enoxaparin
2
2019
19
0.180
Why?
Coronary Vessels
2
2020
125
0.180
Why?
Coronary Vessel Anomalies
2
2020
23
0.180
Why?
Factor Xa Inhibitors
2
2019
38
0.170
Why?
Vascular Diseases
2
2020
82
0.170
Why?
Interleukins
1
2021
89
0.160
Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2021
265
0.150
Why?
Pre-Exposure Prophylaxis
1
2019
19
0.140
Why?
Eosinophils
1
2018
51
0.140
Why?
Inflammasomes
1
2021
354
0.130
Why?
Cardiology
1
2019
172
0.130
Why?
Cardiac Catheterization
1
2019
292
0.120
Why?
Hemorrhage
4
2019
292
0.120
Why?
Anti-Inflammatory Agents
1
2018
169
0.120
Why?
Inpatients
1
2019
324
0.120
Why?
Acute Coronary Syndrome
1
2018
261
0.110
Why?
Time Factors
2
2019
3791
0.110
Why?
Risk Factors
5
2020
5501
0.090
Why?
Inflammation
1
2018
1200
0.090
Why?
Hospitalization
1
2019
1410
0.080
Why?
Anticoagulants
3
2019
534
0.080
Why?
Atrial Fibrillation
1
2018
891
0.070
Why?
Coronary Angiography
2
2020
213
0.070
Why?
Humans
8
2021
66182
0.060
Why?
Stents
2
2020
501
0.050
Why?
Randomized Controlled Trials as Topic
2
2019
815
0.050
Why?
Fibromuscular Dysplasia
1
2020
7
0.040
Why?
Connective Tissue Diseases
1
2020
11
0.040
Why?
Incidental Findings
1
2020
51
0.040
Why?
Stress, Mechanical
1
2020
122
0.040
Why?
Sex Distribution
1
2020
254
0.040
Why?
Age Distribution
1
2020
264
0.040
Why?
Myocardial Ischemia
1
2020
121
0.040
Why?
Takotsubo Cardiomyopathy
1
2020
71
0.040
Why?
Capillaries
1
2018
35
0.030
Why?
Drug Administration Schedule
1
2019
296
0.030
Why?
Clinical Decision-Making
1
2019
170
0.030
Why?
Cardiovascular System
1
2018
41
0.030
Why?
Warfarin
1
2018
125
0.030
Why?
Aspirin
1
2018
173
0.030
Why?
Drug Therapy, Combination
1
2018
464
0.030
Why?
Recurrence
1
2018
668
0.030
Why?
Arrhythmias, Cardiac
1
2018
164
0.030
Why?
Interleukin-1beta
1
2018
278
0.030
Why?
Models, Theoretical
1
2018
269
0.030
Why?
Platelet Aggregation Inhibitors
1
2018
235
0.030
Why?
Critical Illness
1
2019
344
0.030
Why?
Registries
1
2019
938
0.030
Why?
Comorbidity
1
2018
1127
0.030
Why?
Hypertension
1
2020
618
0.030
Why?
Risk Assessment
1
2019
2123
0.020
Why?
Myocardial Infarction
1
2018
923
0.020
Why?
Adult
2
2019
17701
0.020
Why?
Middle Aged
2
2019
18644
0.020
Why?
Stroke
1
2018
1230
0.020
Why?
Aged, 80 and over
1
2019
5706
0.020
Why?
Young Adult
1
2018
4931
0.020
Why?
Treatment Outcome
1
2019
5870
0.020
Why?
Male
2
2019
31630
0.020
Why?
Female
2
2019
34611
0.020
Why?
Aged
1
2019
15254
0.010
Why?
Jafarizade's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (69)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_